ID   Awia-BL
AC   CVCL_ZU71
DR   Wikidata; Q98125521
RX   PubMed=17001014;
RX   PubMed=28960205;
CC   Population: African; Ugandan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
RX   PubMed=17001014; DOI=10.1073/pnas.0509988103; PMCID=PMC1595454;
RA   Kelly G.L., Milner A.E., Baldwin G.S., Bell A.I., Rickinson A.B.;
RT   "Three restricted forms of Epstein-Barr virus latency counteracting
RT   apoptosis in c-myc-expressing Burkitt lymphoma cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14935-14940(2006).
//
RX   PubMed=28960205; DOI=10.1038/cdd.2017.150; PMCID=PMC5762840;
RA   Fitzsimmons L., Boyce A.J., Wei W.-B., Chang C., Croom-Carter D.S.G.,
RA   Tierney R.J., Herold M.J., Bell A.I., Strasser A., Kelly G.L.,
RA   Rowe M.;
RT   "Coordinated repression of BIM and PUMA by Epstein-Barr virus latent
RT   genes maintains the survival of Burkitt lymphoma cells.";
RL   Cell Death Differ. 25:241-254(2018).
//